Riskpilot← Back to searchSign inGet full accessNovalent AB
ABActiveOrg 5561429829Hulda Lindgrens Gata 6 AWholesale of pharmaceutical and medical goods · NACE 4646Est. 197010-19 employees
Revenue 2024
SEK 13M
-44% vs 2024
EBITDA margin
14.5%
-31% vs 2024
Equity ratio
20.5%
Financial strength
Net profit 2024
SEK 1,5M
-18% vs 2024
| Revenue | SEK 13M | -44% |
| EBITDA | SEK 1,9M | -31% |
| Net profit | SEK 1,5M | -18% |
| Total assets | SEK 31,6M | +162% |
| Equity | SEK 6,5M | +57% |
| Employees | — | — |
Legal name
Novalent AB
Org number
5561429829
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23 december 1970
Share capital
SEK 300 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Brattberg, Jan Ernst Labrosse, Anders Gunnar
Company purpose
Bolaget skall bedriva konsultverksamhet, tillverkning, handel och leasing, allt inom data- och elektronikbranschen, handel och förvaltning av värdepapper samt därmed förenlig verksamhet.
Address
Hulda Lindgrens Gata 6 A
Phone
+46317098190
Email
genetec@genetec.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| Revenue | 14 293 | 15 152 | 19 023 | 23 240 | 13 038 |
| Staff expenses | — | — | — | −2 925 | −1 958 |
| EBITDA | 804 | 1 162 | 2 085 | 2 737 | 1 885 |
| Depreciation & amort. | −48 | −48 | −0 | −6 | — |
| EBIT | 756 | 1 114 | 2 085 | 2 731 | 1 885 |
| Net financials | −271 | −349 | −398 | −423 | −214 |
| Profit before tax | 485 | 923 | 1 817 | 2 367 | 1 940 |
| Tax | −107 | −194 | −385 | −502 | −416 |
| Net profit | 378 | 729 | 1 432 | 1 866 | 1 524 |
| Item | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 077 | 9 246 | 10 561 | 12 067 | 31 609 |
| Equity | 2 536 | 2 555 | 3 404 | 4 124 | 6 469 |
| Long-term debt | 1 949 | 2 283 | 2 505 | 2 008 | 5 367 |
| Short-term debt | 3 976 | 3 950 | 4 324 | 5 665 | 19 773 |
| Total debt | 5 925 | 6 233 | 6 829 | 7 673 | 25 139 |
EBITDA margin
14.5%
This company
15.8%
Market median
-8% vs market
20212024
Equity ratio
20.5%
This company
38.2%
Market median
-46% vs market
20212024
Return on equity
23.6%
This company
18.4%
Market median
+28% vs market
20212024
Net profit margin
11.7%
This company
8.1%
Market median
+44% vs market
20212024
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20212024
Debt / equity
3.89×
This company
0.62×
Market median
-527% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-07-01 – 2024-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SH Chief Auditor | Chief Auditor | 2025 |
AG Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
ML Auditor Substitute | Auditor Substitute | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2025 | |
| Chairman | 2022 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Novalent AB 
KOVALENT AktiebolagBoard members of Novalent AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Louise Jonasson | Auditor Substitute | 0 companies |
| Sven Henrik Olsson | Chief Auditor | 0 companies |
| Anders Gunnar Labrosse | Chief Executive Officer | 0 companies |
| Mats Oskar Grapne | Board of Directors | 0 companies |
| Per-Åke Mikael Alfredsson | Board of Directors | 0 companies |
| Jan Ernst Brattberg | Chairman | 0 companies |
| Hans Kristofer Wåhlin | Board of Directors | 0 companies |